Patents by Inventor Marco Cavaleri

Marco Cavaleri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of amide derivative of GE 2270 factor Afor the treatment of acne
    Patent number: 7655676
    Abstract: Use of the compound of formula (I) and the pharmaceutically acceptable addition salts thereof for the manufacture of a medicament for topical treatment or 5 prevention of acne formula (I) wherein: R represents methoxymethyl, R1 represents methyl, Rz represents methyl, Y represents the group formula (II) The compound of formula (I) and the pharmaceutically acid addition salts thereof show selective activity against propionibacterium acne and are suitable for use in a method of treatment or prevention of acne.
    Type: Grant
    Filed: June 6, 2003
    Date of Patent: February 2, 2010
    Assignee: Naicons S.C.A.R.L.
    Inventors: Adriano Malabarba, Marco Cavaleri, Giorgio Mosconi, Daniela Jabes, Gabriela Romano
  • METHODS OF ADMINISTERING DALBAVANCIN FOR TREATMENT OF BACTERIAL INFECTIONS
    Publication number: 20090298748
    Abstract: The invention provides methods and compositions for treatment of bacterial infections. Methods of the invention include administration of dalbavancin for treatment of a bacterial infection, in particular a Gram-positive bacterial infection of skin and soft tissue. Dosing regimes include once weekly administration of dalbavancin, which often remains at therapeutic levels in the bloodstream for at least one week, providing prolonged therapeutic action against a bacterial infection.
    Type: Application
    Filed: May 28, 2009
    Publication date: December 3, 2009
    Inventors: Marco CAVALERI, Daniela JABES, Timothy HENKEL, Adriano MALABARBA, Giorgio MOSCONI, Martin STOGNIEW, Richard J. WHITE
  • Use of amide derivative of ge 2270 factor a3 for the treatment of acne
    Publication number: 20070117825
    Abstract: Use of the compound of formula (I) and the pharmaceutically acceptable addition salts thereof for the manufacture of a medicament for topical treatment or 5 prevention of acne formula (I) wherein: R represents methoxymethyl, R1 represents methyl, Rz represents methyl, Y represents the group formula (II) The compound of formula (I) and the pharmaceutically acid addition salts thereof show selective activity against propionibacterium acne and are suitable for use in a method of treatment or prevention of acne.
    Type: Application
    Filed: June 6, 2003
    Publication date: May 24, 2007
    Inventors: Adriano Malabarba, Marco Cavaleri, Giorgio Mosconi, Daniela Jabes, Gabriela Romano
  • Stable pharmaceutical compositions of dalbavancin and methods of administration
    Patent number: 7115564
    Abstract: The invention provides methods and compositions for treatment of bacterial infections. Methods of the invention include administration of dalbavancin for treatment of a bacterial infection, in particular a Gram-positive bacterial infection of skin and soft tissue. Dosing regimes include once weekly administration of dalbavancin, which often remains at therapeutic levels in the bloodstream for at least one week, providing prolonged therapeutic action against a bacterial infection.
    Type: Grant
    Filed: April 16, 2004
    Date of Patent: October 3, 2006
    Assignee: Vicuron Pharmaceuticals, Inc.
    Inventors: Marco Cavaleri, Daniela Jabes, Timothy Henkel, Adriano Malabarba, Giorgio Mosconi, Martin Stogniew, Richard J. White
  • Methods of administering dalbavancin for treatment of skin and soft tissue infections
    Publication number: 20050130914
    Abstract: The invention provides methods and compositions for treatment of bacterial infections. Methods of the invention include administration of dalbavancin for treatment of a bacterial infection, in particular a Gram-positive bacterial complicated infection of skin and soft tissue. Dosing regimes include once weekly administration of dalbavancin, which often remains at therapeutic levels in the bloodstream for at least one week, providing prolonged therapeutic action against a bacterial infection.
    Type: Application
    Filed: September 15, 2004
    Publication date: June 16, 2005
    Inventors: Marco Cavaleri, Daniela Jabes, Timothy Henkel, Adriano Malabarba, Giorgio Mosconi, Martin Stogniew, Richard White
  • Methods of administering dalbavancin for treatment of bacterial infections
    Patent number: 6900175
    Abstract: The invention provides methods and compositions for treatment of bacterial infections. Methods of the invention include administration of dalbavancin for treatment of a bacterial infection, in particular a Gram-positive bacterial infection of skin and soft tissue. Dosing regimes include once weekly administration of dalbavancin, which often remains at therapeutic levels in the bloodstream for at least one week, providing prolonged therapeutic action against a bacterial infection.
    Type: Grant
    Filed: November 14, 2003
    Date of Patent: May 31, 2005
    Assignee: Vicuron Pharmaceuticals Inc.
    Inventors: Marco Cavaleri, Daniela Jabes, Timothy Henkel, Adriano Malabarba, Giorgio Mosconi, Martin Stogniew, Richard J. White
  • Methods of administering dalbavancin for treatment of skin and soft tissue infections
    Publication number: 20050032721
    Abstract: The invention provides methods and compositions for treatment of bacterial infections. Methods of the invention include administration of dalbavancin for treatment of a bacterial infection, in particular an uncomplicated Gram-positive bacterial infection of skin and soft tissue. Dosing regimes include once weekly administration of dalbavancin, which often remains at therapeutic levels in the bloodstream for at least one week, providing prolonged therapeutic action against a bacterial infection.
    Type: Application
    Filed: September 15, 2004
    Publication date: February 10, 2005
    Inventors: Marco Cavaleri, Daniela Jabes, Timothy Henkel, Adriano Malabarba, Giorgio Mosconi, Martin Stogniew, Richard White
  • Compositions and methods for treating bacterial infections with protein-dalbavancin complexes
    Publication number: 20050004011
    Abstract: The invention provides methods and compositions for treatment of bacterial infections. Methods of the invention include administration of dalbavancin for treatment of a bacterial infection, in particular a Gram-positive bacterial infection of skin and soft tissue, under conditions where a protein-dalbavancin complex forms, or administering a protein-dalbavancin complex. Dosing regimes include once weekly administration of dalbavancin, which often remains at therapeutic levels in the bloodstream for at least one week, providing prolonged therapeutic action against a bacterial infection.
    Type: Application
    Filed: November 14, 2003
    Publication date: January 6, 2005
    Inventors: Marco Cavaleri, Luigi Colombo, Timothy Henkel, Daniela Jabes, Adriano Malabarba, Giorgio Mosconi, Martin Stogniew, Richard White
  • Stable compositions of dalbavancin
    Publication number: 20040224908
    Abstract: The invention provides methods and compositions for treatment of bacterial infections. Methods of the invention include administration of dalbavancin for treatment of a bacterial infection, in particular a Gram-positive bacterial infection of skin and soft tissue. Dosing regimes include once weekly administration of dalbavancin, which often remains at therapeutic levels in the bloodstream for at least one week, providing prolonged therapeutic action against a bacterial infection.
    Type: Application
    Filed: April 20, 2004
    Publication date: November 11, 2004
    Applicant: Vicuron Pharmaceuticals, Inc.
    Inventors: Marco Cavaleri, Daniela Jabes, Timothy Henkel, Adriano Malabarba, Giorgio Mosconi, Martin Stogniew, Richard J. White
  • Methods of administering dalbavancin for treatment of bacterial infections
    Publication number: 20040220122
    Abstract: The invention provides methods and compositions for treatment of bacterial infections. Methods of the invention include administration of dalbavancin for treatment of a bacterial infection, in particular a Gram-positive bacterial infection of skin and soft tissue. Dosing regimes include once weekly administration of dalbavancin, which often remains at therapeutic levels in the bloodstream for at least one week, providing prolonged therapeutic action against a bacterial infection.
    Type: Application
    Filed: April 16, 2004
    Publication date: November 4, 2004
    Applicant: Vicuron Pharmaceuticals, Inc.
    Inventors: Marco Cavaleri, Daniela Jabes, Timothy Henkel, Adriano Malabarba, Giorgio Mosconi, Martin Stogniew, Richard J. White
  • Stable pharmaceutical compositions of dalbavancin and methods of administration
    Publication number: 20040197415
    Abstract: The invention provides methods and compositions for treatment of bacterial infections. Methods of the invention include administration of dalbavancin for treatment of a bacterial infection, in particular a Gram-positive bacterial infection of skin and soft tissue. Dosing regimes include once weekly administration of dalbavancin, which often remains at therapeutic levels in the bloodstream for at least one week, providing prolonged therapeutic action against a bacterial infection.
    Type: Application
    Filed: April 16, 2004
    Publication date: October 7, 2004
    Inventors: Marco Cavaleri, Daniela Jabes, Timothy Henkel, Adriano Malabarba, Giorgio Mosconi, Martin Stogniew, Richard J. White
  • Methods of administering dalbavancin for treatment of skin and soft tissue infections
    Publication number: 20040198715
    Abstract: The invention provides methods and compositions for treatment of bacterial infections. Methods of the invention include administration of dalbavancin for treatment of a bacterial infection, in particular a Gram-positive bacterial infection of skin and soft tissue. Dosing regimes include once weekly administration of dalbavancin, which often remains at therapeutic levels in the bloodstream for at least one week, providing prolonged therapeutic action against a bacterial infection.
    Type: Application
    Filed: April 16, 2004
    Publication date: October 7, 2004
    Applicant: Vicuron Pharmaceuticals, Inc.
    Inventors: Marco Cavaleri, Daniela Jabes, Timothy Henkel, Adriano Malabaraba, Giorgio Mosconi, Martin Stogniew, Richard J. White
  • Methods of administering dalbavancin for treatment of bacterial infections
    Publication number: 20040142883
    Abstract: The invention provides methods and compositions for treatment of bacterial infections. Methods of the invention include administration of dalbavancin for treatment of a bacterial infection, in particular a Gram-positive bacterial infection of skin and soft tissue. Dosing regimes include once weekly administration of dalbavancin, which often remains at therapeutic levels in the bloodstream for at least one week, providing prolonged therapeutic action against a bacterial infection.
    Type: Application
    Filed: November 14, 2003
    Publication date: July 22, 2004
    Inventors: Marco Cavaleri, Daniela Jabes, Timothy Henkel, Adriano Malabarba, Giorgio Mosconi, Martin Stogniew, Richard J. White
  • Injectable formulations containing ramoplanin
    Patent number: 6720305
    Abstract: The present invention relates to a pharmaceutical composition for intravenous administration that contains ramoplanin or a member of the ramoplanin family.
    Type: Grant
    Filed: January 30, 2001
    Date of Patent: April 13, 2004
    Assignee: Vicuron Pharmaceuticals Inc.
    Inventors: Francesco Parenti, Gianpaolo Candiani, Romeo Ciabatti, Marco Cavaleri